Asymmetrically Branched Degradable PEG Derivative Limits Cell Vacuolation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing high-molecular-weight branched polyethylene glycol derivatives cause vacuolation in cells and lack effective degradation mechanisms, limiting their use in modifying bio-related substances.

Innovation Solution

A branched degradable polyethylene glycol derivative with an oligopeptide structure that is stable in blood and degrades intracellularly, featuring specific enzymatic degradation sites to prevent vacuole formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If high-molecular-weight polyethylene glycol (molecular weight 40,000 or more) is used to modify bio-related substances, then the blood half-life is significantly extended, but vacuoles are generated in cells of tissues

Engineering Contradiction:
Improveblood half-lifeVSAvoidvacuole formation in cells
Core Design Contradiction:
Duration of action of moving objectVSObject-affected harmful factors

Solution Approach 1:

The invention changes the molecular weight parameter of polyethylene glycol from high-molecular-weight (40,000 or more) to low-molecular-weight (20,000 or less), specifically using 6,000 or less. This parameter change resolves the contradiction by maintaining the blood half-life extension effect while eliminating vacuole formation in cells, as confirmed by the experimental data showing no vacuoles at molecular weight 20,000 and below

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses low-molecular-weight polyethylene glycol that can be rapidly excreted from the body through kidneys and lungs. This short-living approach allows the polyethylene glycol to perform its blood half-life extension function temporarily without accumulating to toxic levels that cause vacuole formation, enabling safe repeated administration

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Object-affected harmful factors

If the molecular weight of polyethylene glycol is reduced to suppress vacuoles, then vacuole formation is prevented, but the blood half-life cannot be improved sufficiently

Engineering Contradiction:
Improvevacuole formation suppressionVSAvoidblood half-life extension
Core Design Contradiction:
Object-affected harmful factorsVSDuration of action of moving object

Solution Approach 1:

The invention optimizes the molecular weight parameter to a specific range (6,000 or less, preferably 2,000 or less) where the polyethylene glycol maintains sufficient blood half-life extension capability while completely preventing vacuole formation. This precise parameter optimization resolves the contradiction by identifying the optimal molecular weight window that balances both requirements

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a composite structure by combining low-molecular-weight polyethylene glycol with bio-related substances through chemical modification. This composite approach allows the polyethylene glycol to provide its protective and half-life extending functions while its low molecular weight ensures rapid excretion and prevents vacuole formation, achieving both goals simultaneously

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The derivative maintains blood stability and half-life comparable to conventional polyethylene glycol derivatives while preventing vacuole formation in cells, facilitating industrial production with reduced impurities.

Implementation Method 1

a branched degradable polyethylene glycol derivative... that is degraded in the cells... featuring specific enzymatic degradation sites

Methodology Applied
Scientific EffectEnzymatic degradation: Enzyme

Data Source

PatentUS12403199B2Asymmetrically branched degradable polyethylene glycol derivative
Publication Date: 2025.09.02 NOF CORP
  • US12403199B2 patent drawing
  • US12403199B2 patent drawing
  • US12403199B2 patent drawing

AI summary

A branched degradable polyethylene glycol derivative with a high molecular weight that does not cause vacuolation of cells is provided. A branched degradable polyethylene glycol derivative represented by the following formula (1), containing, in a molecule, an oligopeptide that is degraded in the cells:wherein k1 and k2 are each independently 1-12, j1 and j2 are each independently 45-950, R is a hydrogen atom, a substituted or unsubstituted alkyl group having 1-12 carbon atoms, a substituted aryl group, an aralkyl group or a heteroalkyl group, Z is an oligopeptide that is degraded by enzyme in the cells, X is a functional group capable of reacting with a bio-related substance, and L1 and L2 are each independently a single bond or a divalent spacer.